{"data": {"id": "scopus_85168196433", "publication_type_id": 5, "publication_type_label": "Artikel i vetenskaplig tidskrift", "ref_value": "ISREF", "title": "Mediating role of atherogenic lipoproteins in the relationship between liver fat and coronary artery calcification", "pubyear": "2023", "sourcetitle": "Scientific reports", "issn": null, "eissn": null, "sourcevolume": "13", "sourceissue": "1", "sourcepages": "13217", "articlenumber": null, "abstract": "Non-alcoholic fatty liver disease (NAFLD) is associated with increased secretion of apoB-containing lipoproteins and increased risk of coronary heart disease (CHD). ApoB-containing lipoproteins include low-density lipoproteins (LDLs) and triglyceride-rich lipoproteins (TRLs); and since both LDLs and TRLs are causally related to CHD, they may mediate a portion of the increased risk of atherosclerosis seen in people with NAFLD. In a cohort of 4161 middle aged men and women, we performed mediation analysis in order to quantify the mediating effect of apoB-containing lipoproteins in the relationship between liver fat and atherosclerosis-as measured by coronary artery calcium score (CACS). We found plasma apoB to mediate 17.6% (95% CI 11-24) of the association between liver fat and CACS. Plasma triglycerides and TRL-cholesterol (both proximate measures of TRL particles) mediated 22.3% (95% CI 11-34) and 21.6% (95% CI 10-33) of the association respectively; whereas LDL-cholesterol mediated 5.4% (95% CI 2.0-9.4). In multivariable models, the mediating effect of TRL-cholesterol and plasma triglycerides showed, again, a higher degree of mediation than LDL-cholesterol, corroborating the results seen in the univariable models. In summary,\u00a0we find around 20% of the association between liver fat and CACS to be mediated by apoB-containing lipoproteins. In addition, we find that TRLs mediate the majority of this effect whereas LDLs mediate a smaller effect. These results explain part of the observed CAD-risk burden for people with NAFLD and further suggest that TRL-lowering may be particularly beneficial to mitigate NAFLD-associated coronary artery disease risk.", "keywords": null, "publication_identifiers": [{"identifier_code": "scopus-id", "identifier_value": "85168196433"}, {"identifier_code": "doi", "identifier_value": "10.1038/s41598-023-39390-1"}], "authors": [{"affiliations": [{"scopus-afid": "60046006", "scopus-affilname": "Wallenberglaboratoriet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "1", "last_name": "Elias", "first_name": "Bj\u00f6rnson", "identifiers": [{"type": "scopus-auth-id", "value": "56891105300"}]}]}, {"affiliations": [{"scopus-afid": "60046006", "scopus-affilname": "Wallenberglaboratoriet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "2", "last_name": "Dimitrios", "first_name": "Samaras", "identifiers": [{"type": "scopus-auth-id", "value": "58286604500"}]}]}, {"affiliations": [{"scopus-afid": "60046006", "scopus-affilname": "Wallenberglaboratoriet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}, {"scopus-afid": "60016437", "scopus-affilname": "G\u00f6teborgs Universitet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "3", "last_name": "Martin", "first_name": "Adiels", "identifiers": [{"type": "scopus-auth-id", "value": "7801527798"}]}]}, {"affiliations": [{"scopus-afid": "60111964", "scopus-affilname": "Antaros Medical AB", "scopus-affiliation-city": "Uppsala", "scopus-affiliation-country": "Sweden"}, {"scopus-afid": "60003858", "scopus-affilname": "Uppsala Universitet", "scopus-affiliation-city": "Uppsala", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "4", "last_name": "Joel", "first_name": "Kullberg", "identifiers": [{"type": "scopus-auth-id", "value": "23012254700"}]}]}, {"affiliations": [{"scopus-afid": "60046006", "scopus-affilname": "Wallenberglaboratoriet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}, {"scopus-afid": "60031699", "scopus-affilname": "Sahlgrenska Universitetssjukhuset", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "5", "last_name": "Fredrik", "first_name": "B\u00e4ckhed", "identifiers": [{"type": "scopus-auth-id", "value": "57203055879"}]}]}, {"affiliations": [{"scopus-afid": "60046006", "scopus-affilname": "Wallenberglaboratoriet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}, {"scopus-afid": "60031699", "scopus-affilname": "Sahlgrenska Universitetssjukhuset", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "6", "last_name": "G\u00f6ran", "first_name": "Bergstr\u00f6m", "identifiers": [{"type": "scopus-auth-id", "value": "57205318515"}]}]}, {"affiliations": [{"scopus-afid": "60046006", "scopus-affilname": "Wallenberglaboratoriet", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}, {"scopus-afid": "60031699", "scopus-affilname": "Sahlgrenska Universitetssjukhuset", "scopus-affiliation-city": "Gothenburg", "scopus-affiliation-country": "Sweden"}], "person": [{"position": "7", "last_name": "Anders", "first_name": "Gummesson", "identifiers": [{"type": "scopus-auth-id", "value": "8333928900"}]}]}], "source": "scopus", "attended": false}}